Search

Search Constraints

You searched for: Author/Creator Wilhelm, Amanda

Search Results

4. Effects of Long-Term Deutetrabenazine Treatment in Patients with Tardive Dyskinesia and Underlying Psychiatric or Mood Disorders. (April 2022)

5. Expression of bovine non-classical major histocompatibility complex class I proteins in mouse P815 and human K562 cells. (August 2016)

6. Expression of bovine non-classical major histocompatibility complex class I proteins in mouse P815 and human K562 cells. (August 2016)

7. Increased expression of pro‐inflammatory cytokines at the fetal–maternal interface in bovine pregnancies produced by cloning. (16th January 2022)

8. Long-Term Deutetrabenazine Treatment Is Associated With Continued Improvement in Tardive Dyskinesia in the Completed 3-Year Open-Label Extension Study. (April 2021)

9. Long-Term Efficacy and Safety of Deutetrabenazine in Patients with Tardive Dyskinesia by Concomitant Dopamine-Receptor Antagonist Use. (April 2022)